Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hematopoietic and Lymphatic System Neoplasm × Triptorelin Pamoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 20 Breast Neoplasms 4 Sleep Wake Disorders 1 Sarcoma, Ewing 1 Sarcoma 1 Prostate Adenocarcinoma 1 Polycystic Ovary Syndrome 1 Osteosarcoma 1 Lymphoma 1 Infertility 1 Hematopoietic and Lymphatic System Neoplasm 1 Fatigue 1

Interventions

Specimen Handling 2 Triptorelin Pamoate 1 Standard of Care 1 Practice Guidelines as Topic 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06513962 2026-02-24

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Children's Oncology Group

Phase 3 Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡